Dolby Laboratories, Inc. (NYSE:DLB) major shareholder Dagmar Dolby sold 22,069 shares of the business’s stock in a transaction on Friday, July 12th. The shares were sold at an average price of $65.02, for a total transaction of $1,434,926.38. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Wednesday, July 17th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.27, for a total transaction of $6,527,000.00.
  • On Monday, July 15th, Dagmar Dolby sold 72,069 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.10, for a total transaction of $4,691,691.90.
  • On Friday, July 5th, Dagmar Dolby sold 26,358 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.01, for a total transaction of $1,713,533.58.
  • On Wednesday, July 3rd, Dagmar Dolby sold 77,692 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.17, for a total transaction of $5,063,187.64.
  • On Monday, July 1st, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.06, for a total transaction of $3,253,000.00.
  • On Thursday, June 27th, Dagmar Dolby sold 51,777 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.06, for a total transaction of $3,368,611.62.
  • On Tuesday, June 25th, Dagmar Dolby sold 15,617 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.04, for a total transaction of $1,015,729.68.
  • On Friday, June 21st, Dagmar Dolby sold 93,113 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.11, for a total transaction of $6,062,587.43.
  • On Wednesday, May 15th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.05, for a total transaction of $3,252,500.00.
  • On Wednesday, May 8th, Dagmar Dolby sold 46,781 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.12, for a total transaction of $3,046,378.72.

Shares of DLB opened at $65.11 on Friday. The stock has a market capitalization of $6.64 billion, a price-to-earnings ratio of 27.13, a P/E/G ratio of 2.11 and a beta of 0.82. Dolby Laboratories, Inc. has a 12-month low of $58.17 and a 12-month high of $72.04. The company’s fifty day moving average is $63.87.

Dolby Laboratories (NYSE:DLB) last issued its earnings results on Wednesday, May 1st. The electronics maker reported $0.70 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.18. The firm had revenue of $338.26 million during the quarter, compared to analyst estimates of $337.45 million. Dolby Laboratories had a net margin of 24.93% and a return on equity of 11.12%. The business’s revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.73 earnings per share. As a group, sell-side analysts predict that Dolby Laboratories, Inc. will post 2.38 earnings per share for the current fiscal year.

Several institutional investors and hedge funds have recently modified their holdings of the company. Norges Bank purchased a new stake in Dolby Laboratories in the fourth quarter worth about $44,767,000. Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in Dolby Laboratories in the first quarter worth about $22,284,000. Thrivent Financial for Lutherans lifted its stake in Dolby Laboratories by 17.1% in the fourth quarter. Thrivent Financial for Lutherans now owns 1,154,500 shares of the electronics maker’s stock worth $71,394,000 after acquiring an additional 168,214 shares during the period. Chartwell Investment Partners LLC lifted its stake in Dolby Laboratories by 327.9% in the first quarter. Chartwell Investment Partners LLC now owns 218,135 shares of the electronics maker’s stock worth $13,736,000 after acquiring an additional 167,161 shares during the period. Finally, Blair William & Co. IL lifted its stake in Dolby Laboratories by 24.0% in the first quarter. Blair William & Co. IL now owns 849,045 shares of the electronics maker’s stock worth $53,464,000 after acquiring an additional 164,065 shares during the period. 56.00% of the stock is owned by hedge funds and other institutional investors.

DLB has been the subject of a number of recent analyst reports. B. Riley set a $18.00 target price on shares of TiVo and gave the company a “buy” rating in a research note on Thursday, June 13th. ValuEngine raised shares of Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Monday, April 1st. Finally, Zacks Investment Research lowered shares of Inflarx from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Two research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. Dolby Laboratories presently has a consensus rating of “Buy” and a consensus target price of $76.50.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for TVs, set-top boxes (STBs), personal computers (PCs), gaming consoles, mobile devices, and digital radio; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for home theaters, cinemas, device speakers, mobile devices, and headphones.

Recommended Story: How Investors Can Profit from Options Trading

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.